Cargando…
Molecular Diagnosis for Personalized Target Therapy in Gastric Cancer
Gastric cancer is the second leading cause of cancer-related deaths worldwide. In advanced and metastatic gastric cancer, the conventional chemotherapy with limited efficacy shows an overall survival period of about 10 months. Patient specific and effective treatments known as personalized cancer th...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Gastric Cancer Association
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804671/ https://www.ncbi.nlm.nih.gov/pubmed/24156032 http://dx.doi.org/10.5230/jgc.2013.13.3.129 |